Paliperidon Abz (Paliperidone Palmitate)

Paliperidone palmitate, the active ingredient in Paliperidon Abz, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adult patients. GNH USA supplies Paliperidon Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Paliperidon Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidon Abz is used in the management of schizophrenia, a chronic psychotic disorder that affects thought processes and perception.

- Schizophrenia: Reduces frequency and severity of psychotic episodes and supports long‑term symptom control. - Schizoaffective disorder: Helps stabilize mood and psychotic symptoms when used as part of a comprehensive treatment plan. - Maintenance therapy after acute stabilization: Provides continuous antipsychotic coverage to prevent relapse. - Adjunct to oral antipsychotics during transition: Allows gradual switch from daily oral medication to a monthly injectable formulation. - Relapse prevention : Sustains ​      ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​

Paliperidon Abz may exhibit       ​  … 

Common   g   t   t ":[

-   t ":[

The  t ",